MedPath

PAL-PRAVASTATIN-ASA

PAL-PRAVASTATIN-ASA

Discontinued
DIN Number

02272415

Drug Class

Human

Market Date

Jan 13, 2006

Company
HC

paladin pharma inc.

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02272415
AIG Number0251548001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
C10BX02 PRAVASTATIN AND ACETYLSALICYLIC ACID
Product Specifications
Dosage FormKit ,  Tablet ,  Tablet (Delayed-Release)
Route of AdministrationOral
AHFS Classification24:06.08
Health Canada Classification

ACTIVE INGREDIENTS (2)

ACETYLSALICYLIC ACIDActive
Strength: 81 MG
Monograph: ACETYLSALICYLIC ACID
PRAVASTATIN SODIUMActive
Strength: 10 MG
Monograph: PRAVASTATIN SODIUM

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.